Joseph E. De Larco
About
In The Last Decade
Joseph E. De Larco
39 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Molecular Biology 4.1k
- Oncology 2.1k
- Genetics 1.1k
- Cancer Research 959
- Immunology 767
Countries citing papers authored by Joseph E. De Larco
This map shows the geographic impact of Joseph E. De Larco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph E. De Larco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph E. De Larco more than expected).
Fields of papers citing papers by Joseph E. De Larco
This network shows the impact of papers produced by Joseph E. De Larco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph E. De Larco. The network helps show where Joseph E. De Larco may publish in the future.
Co-authorship network of co-authors of Joseph E. De Larco
This figure shows the co-authorship network connecting the top 25 collaborators of Joseph E. De Larco. A scholar is included among the top collaborators of Joseph E. De Larco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph E. De Larco. Joseph E. De Larco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 148 | |
| 3 | 123 | |
| 4 | Induction of invasive and degradative phenotype in normal synovial fibroblasts exposed to synovial fluid from patients with juvenile rheumatoid arthritis: role of mononuclear cell population. | 12 |
| 5 | 47 | |
| 6 | 10 | |
| 7 | 10 | |
| 8 | 116 | |
| 9 | 8 | |
| 10 | 305 | |
| 11 | 64 | |
| 12 | 7 | |
| 13 | 18 | |
| 14 | Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. breakdown → | 754 |
| 15 | 108 | |
| 16 | Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors breakdown → | 463 |
| 17 | Growth factors from murine sarcoma virus-transformed cells. breakdown → | 1215 |
| 18 | 9 | |
| 19 | Nerve growth factor receptors on human melanoma cells in culture. breakdown → | 586 |
| 20 | Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells breakdown → | 309 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.